BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Teva
Fuji
Argus Health
Cantor Fitzgerald
Medtronic
Farmers Insurance
McKinsey
Boehringer Ingelheim
Moodys

Generated: January 21, 2018

DrugPatentWatch Database Preview

Vinorelbine tartrate - Generic Drug Details

« Back to Dashboard

What are the generic sources for vinorelbine tartrate and what is the scope of vinorelbine tartrate patent protection?

Vinorelbine tartrate
is the generic ingredient in two branded drugs marketed by Pierre Fabre, Actavis Totowa, Dr Reddys Labs Ltd, Ebewe Pharma, Fresenius Kabi Usa, Hospira, Jiangsu Hansoh Pharm, Mylan Labs Ltd, Teva Pharms Usa, and West-ward Pharms Int, and is included in eleven NDAs. Additional information is available in the individual branded drug profile pages.

There are fifteen drug master file entries for vinorelbine tartrate. Five suppliers are listed for this compound.
Pharmacology for vinorelbine tartrate
Ingredient-typeVinca Alkaloids
Drug ClassVinca Alkaloid

US Patents and Regulatory Information for vinorelbine tartrate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva Pharms Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076028-001 Feb 3, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pierre Fabre NAVELBINE vinorelbine tartrate INJECTABLE;INJECTION 020388-001 Dec 23, 1994 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Jiangsu Hansoh Pharm VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 091106-001 Sep 26, 2012 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ebewe Pharma VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078408-001 Feb 13, 2008 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 075992-001 Jun 10, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Actavis Totowa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 078011-001 Jul 22, 2009 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076827-001 Jun 2, 2005 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Dr Reddys Labs Ltd VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 202017-001 Sep 12, 2013 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
West-ward Pharms Int VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076461-001 Dec 11, 2003 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa VINORELBINE TARTRATE vinorelbine tartrate INJECTABLE;INJECTION 076849-001 Apr 18, 2005 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Baxter
Moodys
AstraZeneca
UBS
Citi
Cipla
Cerilliant

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot